Biocurious: The cannabis stocks that stand out in a field of weeds
Regulators have lax telehealth prescribers in their sights
Althea Group has sold its medical pot arm in favour of THC-infused beverages
Having sprouted in a field of hope and hype eleven years ago, the ASX medicinal cannabis sector has wilted in the face of unrealistic expectations and misguided strategies.
Demand isn't the problem: patients have embraced medical weed zealously since it was legalised a decade ago.
Globally, most western countries have sanctioned both medical usage and many have condoned recreational indulgence (including most US states).
Because there's only two approved cannabis treatments, local dispensing is largely carried out via an authorised prescriber scheme.
In the six months to December 2024, these docs wrote 377,840 prescriptions. Of these, 230,091 were for products with a THC content of more than 98%.
Patients aren't mucking around.
What's not to like?
The answer is rampant oversupply of the green stuff coupled with the rise of telehealth clinics, some of which are being criticised for alleged 'tick and flick' dispensing practices.
Echoing Australian Medical Association concerns, Little Green Pharma (ASX:LGP) CEO Paul Long refers to 'poor actors' in the local market.
'Reports constantly refer to a handful of doctors, often junior doctors that are either being coerced, or paid exorbitant money to write a huge volume of THC scripts,' he says.
'I agree it is an issue and calling it out for the long-term growth of our industry is important."
He adds hundreds of thousands have tried medical cannabis when nothing has worked, with great success.
Reflecting the 'commoditised' market, Althea Group (ASX:AGH) in May sold its local medical cannabis business, Tasmanian Botanics Pty Ltd for a knock-down $1 million.
'The market has become irrational,' says Althea CEO Joshua Fegan.
'It's very saturated, with product from places like Canada, South Africa and Colombia'.
He says most of the consumption is by way of dried flower, which implies folk might be smoking the devil's lettuce for jollies rather than using it medicinally.
We'll delve further into Althea's new direction below.
The dope on how to get it right
While most suppliers have withered, a handful prosper via differentiated strategies and perhaps a bit of luck. They are producing meaningful revenues and – in some cases - profits.
The Perth-based Little Green Pharma derives 80% of its revenue from the local market, but its greater fortunes align to the rapidly evolving European market.
Germany is in the throes of partial legalisation.
In France, the company supplies a pilot program that's a precursor to legalisation.
Little Green's owns a production facility in Denmark – Europe's biggest – purchased from Canada's Canopy Growth for a knock-down $20 million three years ago.
Two hours from the German border, the facility provides a streamlined route to the biggest Continental markets.
'It's very unlikely a site like this will be built again in the foreseeable future,' Little Green CEO Paul Long says.
Meanwhile, the company's Busselton facility becomes a 'craft' producer of a small amount of slowly cured, hand trimmed, genetically superior stuff.
Naturally, this attracts a better margin.
In the year to March 2025 Little Green grew its revenue by 43%, to a record $36.8 million 'against a backdrop of significant regulatory change and intense competition'.
European revenues doubled.
Adjusted for non-cash items, Little Green managed underlying earnings of $2.9 million compared with a previous $1.6 million loss.
From gummies to suppositories
Bioxyne (ASX:BXN) has a modest $64 million market cap, but that's big enough to confer 'sector leader' status.
Bioxyne's engine room is Breathe Life Sciences (BLS), acquired via scrip in 2023.
BLS makes and distributes medical cannabis and other consumer health products, either under its own brands or third-party labels.
(locally, Bioxyne is also the only licensed maker of MDMA and psilocybin for authorised prescribers and pyschedelic clinical trials).
In 2019 the company launched in the UK and Japan via its well-known Dr Watson brand, covering everything from gummies, to vapes to suppositories.
BLS too has entered the German market with a deal to supply a minimum 1.6 tonnes of cannabis flower and finished product to two clients.
The company expects the agreement will reap a minimum of $5.6 million of revenue in the 2025-26 year.
Ja, das ist gut!
Bioxyne CEO Sam Watson expects German demand to rapidly overtake the $1 billion a year Australian market.
On June 12 the company upgraded full-revenue expectations from $25 million to $28 million, a lofty step up from the previous year's $9.65 million.
The Ebay of medicinal dope
Formerly known as Cronos Australia, Vitura Health (ASX:VIT) doesn't produce any of its own material, but operates a marketplace that sells hundreds of flowers and oils from third party suppliers.
Vitura also has expanded into prescription nicotine vapes.
The company has built a network of physical and online prescribers, mainly via acquisition.
Vitura owns the Canview marketplace, Doctors on Demand telehealth business, CDA Clinics (medical cannabis telehealth) and the clinic chain Candor Medical.
In May, Vitura's 50% joint venture Flora acquired the digital platform Heyday Medical, 'one of Australia's most respected medicinal cannabis clinics'.
Established in 2020, the chain claims to have serviced more than more than 5000 patients.
Last November Flora acquired the Releaf Group, which operates telehealth and physical clinics.
In a March quarter update, Vitura said full-year revenue was unlikely to meet the targeted 10% improvement. But the June quarter implies a yearly run rate of $138 million, up 11%.
Management also expects a 20% improvement on last year's normalised underlying earnings of $8.4 million.
Putting the pep into soft drinks
Coming back to Althea, the company's new schtick is entering the North American market for THC-infused beverages.
(THC is the psychoactive component of cannabis).
Yep, these bevvies are legal in Canada and the US and are sold in bottle shops alongside alcohol.
Althea's foray is by way of its subsidiary Peak.
Althea's Fegan says when Peak started producing in 2021, only 4% of cannabis consumers had tried these drinks. Now, the number is more like one-quarter of them.
He says the drinks have a similar effect to a similar sized serve of alcohol, but without the hangover.
'It ticks a lot of boxes as a good consumer product,' he says.
Peak's competitive edge is its technique to produce the THC emulsion, without the 'planty' taste of dope.
Peak's offerings include seltzers, sodas and mocktails – but it's not yet putting the 'pep' into Pepsi.
Peak Canada has just launched its own brand Snap Back, a heady mix of THC and rosin (pine resin).
By December Althea expects to have four or five US production sites, as close to distributors as possible.
'These big alcohol companies are looking closely at this space and our job is to develop drinks for those type of companies and produce them at scale," Fegan says.
In the December half, Althea derived $8.2 million of revenue in Canada and the company expects this to grow during the summer months.
Given the sale of its Australian business, Althea in May withdrew its full-year guidance of revenue between $26-33 million and underlying earnings of $800,000 to $1.1 million.
Althea lost $2.6 million in the March quarter. But Fegan says the company should be cash flow positive without the drag of the divested Australian business.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

ABC News
8 minutes ago
- ABC News
With numbers stagnating, here's how the league plans to increase AFLW crowds this year
The AFLW burst onto the scene nine years ago with the infamous inaugural lockout game at Prince's Park; over 24,000 filled the stands and thousands more were left outside the gates, unable to get in. Since then, the last three grand finals sold out, 53,034 people flooded Adelaide Oval for the 2019 grand final, 20,652 showed up for the inaugural Showdown in 2022, and the first meeting between Essendon and Hawthorn was forced to move to Docklands after such high demand. Yet crowds have dwindled the past few years, which saw just an average of 2,660 fans rocking up per home-and-away game last season. While this is largely due to inopportune time slots and venues — including a compressed fixture last season with Tuesday and Wednesday night matches and recent expansions diluting audiences — unsurprisingly, one of the AFL's main strategic aims this year is to grow AFLW attendance and fan bases. It also comes amid reports of the AFL telling all 18 clubs the women's game is losing $50 million a year. However, AFL executive general manager of strategy Walter Lee stressed the league was not worried about the long-term viability of the competition. "I want to reiterate, the competition is here to stay. We are investing, but it is here to stay," he said. "When you sort of take a 10-year vision around this kind of investment, this is no different from how we invest into Western Sydney [or] Gold Coast … It's long-term. It's trying to be visionary about it." So, here's how the league is aiming to get more bums on seats this season. Josh Bowler, AFL's head of strategy and scheduling, said this season had gone "back to a more traditional fixture structure" after trialling the compressed fixture last season, which squeezed 11 rounds into 10 weeks. While this impacted the product, with some teams playing four games within 15 days, and made it hard for crowds to get to midweek games, it also contributed to the "footy fatigue" many fans feel at the back end of the year. Yet even before that, attendance took a hit after the move to the suburban grounds two years prior. For example, Essendon and Hawthorn's inaugural 2022 clash at Docklands attracted 12,092 spectators, yet just 3,778 when the clubs played each other in Frankston the following year. Another reason for smaller crowds has been the rapid expansions. Total attendance has risen by 52 per cent since season one (195,000 to 297,000), however, with more teams in the competition, the attendance has become more diluted. This year, the season length has increased to 12 rounds within 12 weeks. It could move to 14 by 2027, but to make that move, the league must first meet key metrics agreed to by the AFL and the AFL Players' Association: an average attendance of 6,000 fans and 100,000 broadcast viewers per match. In 2023, a key metric target was an average crowd attendance of 3,500. The ABC asked the AFL what its internal targets were for this season, but the league said they would not release those publicly to avoid making them an ongoing narrative. Lee said a focus this year was "fan-friendly time slots", venue consolidation and allowing for rituals to be created around home venues. "We're playing in too many different time slots, and we're playing in too many different venues as well. And so as a fan, how do you format ritual?" he said. "Take an example with Melbourne. They played seven matches here in Victoria [last season] and in seven different time slots … So it's really hard as a fan to build that ritual." One initiative not being utilised in fixturing this year — despite the majority of clubs actively campaigning the league for it — is double-headers. When the fixture came out earlier this year, AFLPA chief Ben Smith said the union provided the AFL with a submission based on player feedback that included a desire for more "category-one venues and the opportunity to play some double-headers". The AFL said they did not want to compromise on atmosphere if the crowds weren't there yet to support it. Last season, the Western Bulldogs' round-two AFLW match was rescheduled at the last minute to a double-header with the men's elimination final at the MCG to avoid a club fixture clash. The league used this as an example of why double-headers wouldn't work in the short term. However, that match was organised the week of, with the women's game starting at 4.30pm on the Friday afternoon, before the men's clash at 7:40pm. "Even though there were 23,000 recorded [in attendance], the atmosphere at 23 per cent utilisation isn't what we're trying to project," Lee said. "I guess the conclusion is, like, 30,000, 40,000 — that's when it starts to get sort of more exciting." GWS was one of the clubs that were "strong advocates" for double-headers in the two-round crossover between the end of the men's home-and-away season and the AFLW, believing it would work for their market. "We're a young club with a new audience, a new fan base, and we want to be able to build that across our men's and women's program," GWS general manager of AFLW and football operations Alison Zell told ABC Sport. Bowler added that "the W needs to be built around AFLW", in venues that work for its product, and not fit in with the men's competition. The lack of double-headers has also contributed to no category-one venues being used for AFLW this year, limiting the ability to get crowds above the 20,000-plus mark for bigger games. While part of this is to encourage fans to create rituals at grounds such as Whitten Oval and Windy Hill, the league said it wouldn't move to larger stadiums until the crowds supported it. Players have consistently advocated for some marquee games to be played at larger stadiums, such as the Showdown at Adelaide Oval. Last year, AFL executive general manager of football Laura Kane told The Sydney Morning Herald that for future AFLW matches to be played at Docklands Stadium, games would need to attract 20,000 supporters to justify using the venue. Kane said Arsenal Women were a great example of knowing when to move from a 5,500-seat stadium to 50,000 in the Women's Super League overseas. "What was really interesting to me is how strategic they were with the one, two or three times that they triggered that big stadium experience," Kane said. "[Filling the stadium] wasn't because they hoped, it wasn't because they thought 'maybe they'll come'. It wasn't because they thought, 'let's strategically try and leverage the men's'. It was because they knew they were ready. "So the patience in that … [And] in every single fan survey or every question we ask of our fans, they absolutely love that closeness to the players, [and] the fullness of the stadiums. And so it's one of the single biggest things, biggest decisions and strategic priorities we have is where we play." Improving the on-field product is another main strategic aim for the league. "We know what people like watching, because we have AFL every weekend to look at, what are the things that people enjoy?" Kane said. "They enjoy close games, unpredictable finishes, lead changes, you know, so on and so forth and so, how do we do that? … Investing in the pathway of the young players is the answer for us." Kane said the metrics spoke for themselves with the talent in the pathways entering the system. One of the biggest factors to help improve the product, Laura Kane said, was time. "The quality of the under-18 games is unbelievable compared to what we've seen 5, 6, 7, 8 years ago." However, in the now, the AFL is strong on wanting an attacking style from teams. Essendon and the Western Bulldogs' "ugly" clash at the end of the condensed fixture last year was widely criticised for the defensive style of play from both sides. Essendon won 3.8 (26) to 0.3 (3). "I think Scott Gowans was interviewed last year and said it himself, like, we might lose by a big margin, but we're committed to playing an offensive, attacking style," Kane said. "It's a lot on the ability of the players to execute the skills, but it's also on us to help set up a framework that allows them to do that more easily." AFLW's new general manager of women's football, Emma Moore, said the AFL wanted to harness what she was calling the "Caitlin Clark effect": an increase in women's sport viewership and attendance driven by stardom. This would mean attracting fans to AFLW because of a big name like Sam Kerr (soccer) and Caitlin Clark (WBNA). "The huge opportunity that we have in AFLW is the vast volume of players that we have to begin with, and the incredible skills, personalities and champions of themselves and the sport they play, what they bring," Moore said. "So we really want to unlock that opportunity for them and so it's really clear for us that going forwards, a key play in growing our fan base is growing that connection between our fans and their players."

News.com.au
8 minutes ago
- News.com.au
‘Trusted name': Iconic airline makes comeback after more than 20 years – as an AI-powered travel agency
More than 20 years after closing its doors, Ansett is back – this time, as an AI-powered travel agency. Ansett Airlines – later Ansett Australia – served as the country's second-largest since 1936 before it was placed into voluntary administration and ceased operations in 2002, resulting in a loss of 16,000 jobs. Before its closure, the airline was once a mainstay of Australian culture as one of the major sponsors of the AFL and the major sponsor for the 2000 Sydney Olympics. Last month, Melbourne entrepreneur Constatine Frantzeskos announced the airline's return as an AI-powered travel agency after 'the famous Ansett trademark had lapsed'. 'Ansett is back – reborn as Australia's first truly AI-run travel agency,' he wrote on LinkedIn. 'I registered the trademark, created a fleet of AI agents, and – thanks to a tech integration with Travlr – have now turned Ansett into a one-founder online travel agency.' The Ansett Travel website is powered by AI and designed to offer a 'personalised' experience. 'We use a combination of large language models, recommendation systems, and predictive pricing engines,' the website read. 'Our AI helps personalise your journey, surface better deals faster, and automate the back-end processes that traditional OTAs still handle manually.' According to the company's website, the travel agency operates with 500 airlines and three million hotels and aims to '(revive) a trusted name' and '(give) it a new identity'. Speaking to The Sydney Morning Herald, Mr Frantzeskos said Ansett Travel was 'building the personal travel agent of the future'. According to the website, the company is not 'trading on nostalgia'. 'The Ansett name still holds meaning – especially for Australians who remember a time when travel felt innovative, considered, personal, and premium,' the website read. 'We're not trading on nostalgia – we're reviving a trusted name and giving it a new identity: intelligent, intuitive, and value-driven.'

Mercury
24 minutes ago
- Mercury
PNN secures Pocitos water drilling approval
Special Report: Power Minerals has received the green light to carry out hydrological drilling to advance its Rincon Lithium joint venture project in Argentina's Salta province. Power Minerals gets approval for hydrological drilling at Rincon joint venture in Argentina's Salta province Drilling targets industrial water source needed for direct lithium extraction operations at Pocitos project Navigate Energy poised to release US$4 million investment commitment for JV The drilling at the Pocitos project within the JV area is aimed at securing an industrial water source, which is essential for direct lithium extraction operations. This program will explore freshwater resources within the extensive alluvial fan northeast of the Pocitos salar. Finding a source of industrial water will strengthen Power Minerals' (ASX:PNN) plan to establish the Rincon JV with Navigate Energy as a lithium carbonate production hub in South America. 'Moving ahead with drilling to identify an industrial water source helps us progress our development plans,' managing director Mena Habib said. 'Pocitos has the potential to offer this required water source and we look forward to seeing what drilling will reveal.' Pocitos project The Pocitos project sits within Salta province in South America's famed lithium triangle, a region recognised as the go to destination for lithium brines drawing majors and juniors alike. Pocitos itself benefits from direct access to the General Belgrano Railway connecting to Pacific (Chile) and Atlantic (Argentina) ports, integration with existing natural gas pipelines and connection to the Cauchari and Altiplano solar farms, and support from a reliable legal and regulatory mining framework along with a skilled workforce. Ongoing infrastructural improvements such as the paving of highway Route 27, a planned high-voltage electrical connection from Cauchari, and a 435-hectare industrial park at Pocitos, add further to the project's strength. PNN adds that integration of the Rincon JV entity is nearing completion, which will release US$4 million in investment from Navigate Energy as part of its commitment. This includes funding dedicated to both Rincon and Pocitos development activities. The broader Rincon JV area has a JORC resource of 292,564t lithium carbonate equivalent at a lithium concentration of 248mg/L. Development will be through the use of direct lithium extraction, which has been proven to deliver substantial cost, water, and energy savings compared to traditional methods. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions. Originally published as Power Minerals gains water drilling approval to advance Pocitos lithium production hub